| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/19/2005 | EP1497438A1 Means and methods for the production of adenovirus vectors |
| 01/19/2005 | EP1497436A1 Compositions for delivering enzymes involved in amino acid metabolism using recombinant adeno-associated virus virons (raav virons), and method and use for treating amino acid metabolic disorders using such raav virons |
| 01/19/2005 | EP1497435A2 Placental derived stem cells and uses thereof |
| 01/19/2005 | EP1497425A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle |
| 01/19/2005 | EP1497412A2 Adenovirus vectors for immunotherapy |
| 01/19/2005 | EP1497410A2 Cellular transplantation for heart regeneration |
| 01/19/2005 | EP1497306A1 Alternatively spliced nucleic acid molecules |
| 01/19/2005 | EP1496978A2 Improvements of adipocytic differentiated adipose derived adult stem cells and uses thereof |
| 01/19/2005 | EP1496947A1 Removal of adenine during a process of pathogen reducing blood and blood components |
| 01/19/2005 | EP1496923A1 Cancer immunotherapy |
| 01/19/2005 | EP1496919A2 Immobilisation and stabilisation of virus |
| 01/19/2005 | EP1496875A1 Use of a mare's milk concentrate dried on a highly-dispersed, biologically inert matrix |
| 01/19/2005 | EP1496824A2 Tissue composites and uses thereof |
| 01/19/2005 | EP1404812A4 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease |
| 01/19/2005 | EP0789588B1 Method for making a medicament for treating secondary immunodeficiency |
| 01/19/2005 | EP0545946B1 Growth-promoting agent |
| 01/19/2005 | CN1568365A Composition comprising a lactobacillus pentosus strain and uses thereof |
| 01/19/2005 | CN1568206A Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leuko-filter |
| 01/19/2005 | CN1568195A Peptide YY and peptide YY agonists for treatment of metabolic disorders |
| 01/19/2005 | CN1568194A Modulation of smooth muscle cell proliferation |
| 01/19/2005 | CN1568193A Use of il-18 inhibitors in hypersensitivity disorders |
| 01/19/2005 | CN1566358A Enzymolysis product of animal brain and its preparation method and pharmaceutical use |
| 01/19/2005 | CN1566326A Lactobacillus casei LC2W strain and its application in treatment of high blood pressure |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565541A Osteodynia alleviating and wind dispelling liniment |
| 01/19/2005 | CN1565481A Prescription of a beautifying honey product |
| 01/19/2005 | CN1565480A Externally used medicine for tracheitis and cough |
| 01/19/2005 | CN1565479A Musk liposome injection and its preparation method |
| 01/19/2005 | CN1565478A Musk medicated thread and its preparation method |
| 01/19/2005 | CN1565423A Ultra fine egg shell powder preparation method |
| 01/19/2005 | CN1185019C Dermal scaffold comprising nutralized chitosan sponge, nutralized chitosan/collagen mixed sponge |
| 01/19/2005 | CN1185007C Fat reducing and thrombosis dissolving medicine |
| 01/19/2005 | CN1185006C Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof |
| 01/19/2005 | CN1184999C Chinese medicinal herbs ointment and preparing method thereof |
| 01/19/2005 | CN1184996C Medicine for treating children diarrhea |
| 01/19/2005 | CN1184995C Kidney-strengthening and pregnancy assisting granule |
| 01/19/2005 | CN1184993C Medicine for treating psoriasis |
| 01/19/2005 | CN1184992C Chinese patent medicine for treating paraplegia |
| 01/19/2005 | CN1184991C Chinese traditional medicine preparation for treating glomerulonephritis |
| 01/19/2005 | CN1184988C Chinese medicine for treating liver cancer, pancreatic cancer and other malignant tumors |
| 01/19/2005 | CN1184985C Tumor treating capsule and its inspecting method thereof |
| 01/19/2005 | CN1184984C Chinese-medicinal ointment for treating burn and scald and its preparing process |
| 01/19/2005 | CN1184983C Chinese medicine compositions for regenerating hair |
| 01/19/2005 | CN1184982C Gastric and duodenum ulcer treating capsule and its preparation |
| 01/19/2005 | CN1184977C Yin nourishing and kidney reinforcing medicine |
| 01/19/2005 | CN1184974C Traditional Chinese medicine compositions for treating prostatitis, impotence and ejaculation praecox |
| 01/19/2005 | CN1184973C Thrombolytic leech soft capsule and its preparing method |
| 01/18/2005 | US6844424 Using birds bone derivatives to replace cattle sources of cartilage in nutrients, veterinary medicine and cosmetics; prevention of prion and/or viral diseases |
| 01/18/2005 | US6844325 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
| 01/18/2005 | US6844317 Methods for oxygen transport comprising a high oxygen affinity modified hemoglobin |
| 01/18/2005 | US6844314 Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/18/2005 | US6844191 Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein |
| 01/18/2005 | US6844014 Corn starch, zinc oxide, carboxymethylcellulose, colostrum, methylparaben, propylparaben, calendula, hypericum, aloe, glycerine, vitamin E and deionized water; relieving skin inflammation and sensitivity; nonantibiotic, nonsteroidal |
| 01/18/2005 | US6844011 Methods for inhibiting rejection of transplanted tissue |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |
| 01/18/2005 | US6843961 Deactivation pathogens; using riboflavin sensitizers; exposure to light source |
| 01/18/2005 | CA2251889C Process for producing and multiplying lymphocytes |
| 01/18/2005 | CA2149324C Fluidized intestinal submucosa and its use as an injectable tissue graft |
| 01/13/2005 | WO2005003335A2 Rapamycin resistant t cells and therapeutic uses thereof |
| 01/13/2005 | WO2005003334A2 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/13/2005 | WO2005003333A2 Use of umbilical cord blood stem cells for preventing brain damage due to lack of oxygen and providing neuroprotection |
| 01/13/2005 | WO2005003328A1 A method and agents for improving plant productivity involving endophytic actinomycetes and metabolites thereof |
| 01/13/2005 | WO2005003321A2 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | WO2005002616A1 Pharmaceutical active ingredient to combat tumours containing loxoscelidae spider toxin |
| 01/13/2005 | WO2005002612A1 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 01/13/2005 | WO2005002607A2 Oncolytic reoviruses for the treatment of neoplasms having activated pp2a or rac |
| 01/13/2005 | WO2005002606A1 Use of a single-cell protein material |
| 01/13/2005 | WO2005002605A1 Fish protein hydrolyzate |
| 01/13/2005 | WO2005002604A1 Pharmaceutical active ingredient to combat tumours |
| 01/13/2005 | WO2005002603A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 01/13/2005 | WO2005002602A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus and insulin resistance |
| 01/13/2005 | WO2005002601A1 Conditioned matrix compositions for tissue restoration |
| 01/13/2005 | WO2005002600A2 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus |
| 01/13/2005 | WO2005002581A1 Use of osmolytes obtained from extremophilic bacteria for producing medicaments for the external treatment of neurodermatitis |
| 01/13/2005 | WO2005002499A2 A method and therapeutic platelets |
| 01/13/2005 | WO2005002494A2 Pharmaceutical active ingredient to combat prostatic cancer |
| 01/13/2005 | WO2004099422A3 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 01/13/2005 | WO2004000213A9 Method for growing human organs, treating diseases, and increasing longevity |
| 01/13/2005 | US20050010966 Using nuclear transplantion of somatic cell genome to transform and generate cloned non-human mammal; bioengineering; tissue engineering |
| 01/13/2005 | US20050009736 Administering by hemodilution an aqueous cell-free polyalkylene oxide surface modified hemoglobin without intramolecular crosslinking; oxygen affinity greater than whole blood; blood disorders |
| 01/13/2005 | US20050009186 Expression vector comprising 3' and 5' long terminal repeats and preferential splice junctions for use as heterologous gene transfer tool; gene therapy |
| 01/13/2005 | US20050009184 Humanised baculovirus |
| 01/13/2005 | US20050009181 Contacting bone marrow stromal cells with neuronal and/or endodermal precursor tissue, transfecting diffferentiated endoderm/neuronal tissues with vector comprising therapeutic protein for use in treatment of cancer, diabetes, pancreatitis, liver and inflammatory bowel diseases |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050008708 Forming, preservation modelable biopolymer; harvesting tissue, deactivation of infections; applying pressure; tissue engineering |
| 01/13/2005 | US20050008628 Polynucleotide gene expression construction; therapy of diseases caused by damage to excitable tissue; cardiovascular disorders therapy; antidiabetic agents; Parkinson's disease; antiepileptic agents; neurodegenerative agents |
| 01/13/2005 | US20050008627 Administering tumor necrosis factor directly to lungs; asthma therapy; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050008626 Removing adipose tissues; controlling concentration of stem cells; congestive heart failure |
| 01/13/2005 | US20050008624 Expansion of renewable stem cell populations |
| 01/13/2005 | US20050008623 In vitro production of dendritic cells from CD14+ monocytes |
| 01/13/2005 | US20050008622 Clinical application of dendritic cell-based cancer immunotherapy |
| 01/13/2005 | US20050008621 Preadipocyte cell strains and uses therefore |
| 01/13/2005 | DE10328252A1 Pharmazeutischer Wirkstoff Active Pharmaceutical Ingredient |
| 01/13/2005 | DE10328251A1 Pharmazeutischer Wirkstoff Active Pharmaceutical Ingredient |
| 01/13/2005 | CA2799684A1 Monitoring and control system for blood processing |
| 01/13/2005 | CA2799683A1 Monitoring and control system for blood processing |
| 01/13/2005 | CA2799526A1 Monitoring and control system for blood processing |
| 01/13/2005 | CA2542401A1 Use of a single-cell protein material |
| 01/13/2005 | CA2542396A1 Fish protein hydrolyzate |